Patients with diabetes were treated with lifestyle modification (n = 44), oral antidiabetic agents (n = 43), or combination therapies with insulin (n = 2), resulting in adequate glycemic control (hemoglobin A1c 6.5 ± 0.9%). This evidence concerns the gene INS and diabetes mellitus.